What it Means to Implement ICH GCP R3 – Site vs Sponsor

Join us for an engaging and practical session focused on the latest ICH E6(R3) updates in clinical research. This webinar will guide attendees in understanding, responding to, and implementing R3 requirements from both site and sponsor perspectives through real-world examples in clinical operations, protocol management, and documentation.

Learning Outcomes

After completing this workshop, participants will be able to:

1. Understand key changes and revisions from R2 to R3
2. Effectively implement R3 requirements as a site
3. Effectively implement R3 requirements as a sponsor

🎓 Participants will receive 1 CEU (Continuing Education Unit) for attending this session.

Speaker Bio

Jeannie Farnsworth
Senior Director of Clinical Research and Biomarker Services, CND Life Sciences

Jeannie Farnsworth is a seasoned clinical researcher with over 25 years of experience in drug, biologic, and device clinical trials across all four phases. She has worked in both public and private sectors—spanning site and industry roles—with therapeutic experience that includes pediatric endocrinology, diabetes, ophthalmology, gastroenterology, oncology, first-in-human, and neurology.

Her passion for clinical research began early, shaped by meaningful relationships with pediatric and elderly study participants during their most vulnerable stages of life. Today, Jeannie leads clinical research teams in executing a diverse portfolio of studies aimed at uncovering insights and driving better decision-making in medicine.